Volume 62, Issue 4, Pages (October 2002)

Slides:



Advertisements
Similar presentations
Volume 62, Pages S12-S22 (December 2002)
Advertisements

Novel Role of Toll-Like Receptor 3 in Hepatitis C-Associated Glomerulonephritis  Markus Wörnle, Holger Schmid, Bernhard Banas, Monika Merkle, Anna Henger,
Volume 83, Issue 5, Pages (May 2013)
Volume 65, Issue 1, Pages (January 2004)
Volume 58, Issue 4, Pages (October 2000)
Volume 59, Issue 3, Pages (March 2001)
Volume 69, Issue 6, Pages (March 2006)
Volume 76, Issue 1, Pages (July 2009)
Volume 56, Issue 4, Pages (October 1999)
Volume 71, Issue 6, Pages (March 2007)
Requirement of heat shock protein 90 in mesangial cell mitogenesis
Volume 54, Issue 3, Pages (September 1998)
Volume 62, Issue 6, Pages (December 2002)
Volume 55, Issue 2, Pages (February 1999)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 82, Issue 1, Pages (July 2012)
Volume 62, Issue 4, Pages (October 2002)
Volume 62, Issue 2, Pages (August 2002)
Volume 64, Issue 1, Pages (July 2003)
Volume 60, Issue 2, Pages (August 2001)
Volume 56, Issue 1, Pages (July 1999)
Volume 75, Issue 10, Pages (May 2009)
Volume 54, Issue 1, Pages (July 1998)
Genistein protects the kidney from cisplatin-induced injury
Volume 56, Issue 3, Pages (September 1999)
Volume 61, Issue 1, Pages (January 2002)
Volume 63, Issue 1, Pages (January 2003)
Volume 56, Issue 6, Pages (December 1999)
Volume 59, Issue 1, Pages (January 2001)
Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity  Zhang-Xu Liu, Sugantha Govindarajan,
Volume 56, Issue 3, Pages (September 1999)
A new mouse model of immune-mediated podocyte injury
Fan Zhang, Yaw L. Siow, Karmin O  Kidney International 
Volume 70, Issue 7, Pages (October 2006)
Volume 62, Issue 4, Pages (October 2002)
Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric rats  Gopala K. Rangan, Yiping Wang, Yuet-Ching Tay,
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
Volume 58, Issue 3, Pages (September 2000)
Volume 53, Issue 5, Pages (May 1998)
Volume 58, Issue 1, Pages (July 2000)
Volume 73, Issue 7, Pages (April 2008)
Akito Maeshima, Yoshihisa Nojima, Itaru Kojima  Kidney International 
Volume 73, Issue 1, Pages (January 2008)
Volume 57, Issue 3, Pages (March 2000)
Volume 70, Issue 2, Pages (July 2006)
Volume 65, Issue 3, Pages (March 2004)
Volume 61, Issue 6, Pages (June 2002)
Volume 67, Issue 1, Pages (January 2005)
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry  Miguel Angel Hernández-Presa, Carmen Gómez-Guerrero,
Volume 60, Issue 6, Pages (December 2001)
Volume 53, Issue 4, Pages (April 1998)
Volume 62, Issue 5, Pages (November 2002)
Volume 62, Pages S12-S22 (December 2002)
Volume 66, Issue 4, Pages (October 2004)
Volume 61, Issue 3, Pages (March 2002)
Volume 64, Pages S33-S38 (October 2003)
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Volume 65, Issue 6, Pages (June 2004)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Barbara A. Bresnahan, Shelly Dufek, Shenghua Wu, Elias A. Lianos, M.D. 
Volume 59, Issue 5, Pages (May 2001)
Volume 56, Issue 6, Pages (December 1999)
Volume 61, Issue 6, Pages (June 2002)
Volume 63, Issue 1, Pages (January 2003)
Volume 58, Issue 3, Pages (September 2000)
Cultured human glomerular mesangial cells express the C5a receptor
Bismarck Amoah-Apraku, Mao-Zhong Fang, Nicolas J. Guzman, M.D 
Volume 118, Issue 6, Pages (June 2000)
Volume 56, Issue 4, Pages (October 1999)
Presentation transcript:

Volume 62, Issue 4, Pages 1264-1276 (October 2002) Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells  Uwe Haberstroh, Johanna Pocock, Carmen Gómez-Guerrero, Udo Helmchen, Alf Hamann, Jose C. Gutierrez-Ramos, Rolf A.K. Stahl, Friedrich Thaiss  Kidney International  Volume 62, Issue 4, Pages 1264-1276 (October 2002) DOI: 10.1111/j.1523-1755.2002.kid572.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Glomerular RANTES/CCL5 mRNA expression. Rats pretreated or non-pretreated for monocyte/macrophage depletion (N = 3) were injected intraperitoneally with lipopolysaccharide (LPS). Glomerular RANTES/CCL5 mRNA expression was determined at time intervals after LPS injection. (A) Expression 6 hours after LPS-injection in animals not-pretreated (PBS) or pretreated with a rabbit anti-rat monocyte/macrophage antiserum (a-M/M), an irrelevant rabbit antiserum (a-J) or nitrogen mustard (NM). (B) Expression at 1, 3 and 6 hours after LPS-injection in rats pretreated or not with cyclophosphamide (CyP). (C) Expression at 1, 3 and 6 hours after LPS-injection in rats pretreated or not with a rabbit anti-rat monocyte/macrophage antiserum (a-RM). The figures are representative of two independent complete sets of experiments. Significance values are: *P < 0.05 when compared with controls; #P < 0.05 when compared with non-pretreated animals after LPS-injection. Kidney International 2002 62, 1264-1276DOI: (10.1111/j.1523-1755.2002.kid572.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Glomerular RANTES/CCL5 mRNA expression. Rats pretreated or non-pretreated for monocyte/macrophage depletion (N = 3) were injected intraperitoneally with lipopolysaccharide (LPS). Glomerular RANTES/CCL5 mRNA expression was determined at time intervals after LPS injection. (A) Expression 6 hours after LPS-injection in animals not-pretreated (PBS) or pretreated with a rabbit anti-rat monocyte/macrophage antiserum (a-M/M), an irrelevant rabbit antiserum (a-J) or nitrogen mustard (NM). (B) Expression at 1, 3 and 6 hours after LPS-injection in rats pretreated or not with cyclophosphamide (CyP). (C) Expression at 1, 3 and 6 hours after LPS-injection in rats pretreated or not with a rabbit anti-rat monocyte/macrophage antiserum (a-RM). The figures are representative of two independent complete sets of experiments. Significance values are: *P < 0.05 when compared with controls; #P < 0.05 when compared with non-pretreated animals after LPS-injection. Kidney International 2002 62, 1264-1276DOI: (10.1111/j.1523-1755.2002.kid572.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Glomerular MCP-1/CCL2 mRNA expression. In rats pretreated or non-pretreated for monocyte/macrophage depletion (N = 3) glomerular MCP-1/CCL2 mRNA expression was determined. (A) Expression at 1, 3 and 6 hours after LPS-injection in rats pretreated or not with cyclophosphamide (CyP). (B) Expression at 1, 3 and 6 hours after LPS-injection in rats pretreated or not with a rabbit anti-rat monocyte/macrophage antiserum (a-RM). (C) Expression at 24 hours and 5 days after the induction of anti-Thy 1.1-nephritis in rats pretreated or not with cyclophosphamide (CyP). The figures are representative of two independent complete sets of experiments. Significance values are: *P < 0.05 when compared with controls; #P < 0.05 when compared with non-pretreated animals. Kidney International 2002 62, 1264-1276DOI: (10.1111/j.1523-1755.2002.kid572.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Glomerular intracellular adhesion molecule-1 (ICAM-1) and proliferating cell nuclear antigen (PCNA) protein expression. In rats pretreated or non-pretreated for monocyte/macrophage depletion (N = 2) glomerular protein expression was determined by Western blotting. Expression was determined at 6 hours after LPS injection in animals not-pretreated (PBS) or pretreated with a rabbit anti-rat monocyte/macrophage antiserum (a-M/M), an irrelevant rabbit antiserum (a-J) or nitrogen mustard (NM). The figure is representative of three independent complete sets of experiments. Kidney International 2002 62, 1264-1276DOI: (10.1111/j.1523-1755.2002.kid572.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Glomerular nuclear factor-κB (NF-κB) DNA binding activity. In rats pretreated or non-pretreated for monocyte/macrophage depletion (N = 2) glomerular nuclear proteins were isolated from controls and after LPS was injected intraperitoneally and NF-κB consensus DNA binding activity determined by gel shift experiments (EMSA). (A) NF-κB binding activity at 6 hours after LPS (lane 2) when compared with control animals (lane 1; P < 0.05) and rats pretreated with nitrogen mustard (lane 3) or anti-monocyte/macrophage antiserum (lane 4). (B) EMSA in rats non-pretreated (lanes 1-4) or pretreated with cyclophosphamide (CyP) (lanes 5-8) in controls (lanes 1 and 5) and after LPS-injection. (C) NF-κB binding activity in non-pretreated (lanes 1-4) or animals pretreated with anti monocyte/macrophage antiserum (a-RM) (lanes 5-8) in controls (lanes 1 and 5) and after LPS injection. The figures are representative of two independent complete sets of experiments. Kidney International 2002 62, 1264-1276DOI: (10.1111/j.1523-1755.2002.kid572.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 Southwestern histochemistry for NF-κB. In controls and rats 3 hours after LPS injection (N = 2) NF-κB binding was localized in the glomeruli by Southwestern histochemistry. In additional experiments double staining for ED1-positive monocytes/macrophages was performed. Closed arrows indicate nuclear localization of NF-κB, and open arrows indicate cells that stained positive for NF-κB and simultaneously ED-1 (magnification ×720). (Reproduction of this figure in color was made possible by a grant from Aventis Pharma, Bad Soden, Germany.) Kidney International 2002 62, 1264-1276DOI: (10.1111/j.1523-1755.2002.kid572.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 6 Staining for monocytes/macrophages in LPS-treated mice. Renal tissue from ICAM-1 wild type and ICAM-1 knockout mice (N = 2) was stained for MCA519-positive monocytes/macrophages in controls and 3, 6, 12 and 24 hours after LPS injection. (A) Representative sections are given for glomeruli and tubulo-interstitium at 6 hours after LPS injection. (Reproduction of this figure in color was made possible by a grant from Aventis Pharma, Bad Soden, Germany.) (B) Quantification of MCA519-positive cells per glomerular cross sectional and interstitial areas in time intervals after LPS-injection. Symbols are: (▪) ICAM-1 wild-type mice; (□) ICAM-1 knockout mice; *P < 0.05 when wild-type animals were compared with ICAM-1 knockout mice. Kidney International 2002 62, 1264-1276DOI: (10.1111/j.1523-1755.2002.kid572.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 6 Staining for monocytes/macrophages in LPS-treated mice. Renal tissue from ICAM-1 wild type and ICAM-1 knockout mice (N = 2) was stained for MCA519-positive monocytes/macrophages in controls and 3, 6, 12 and 24 hours after LPS injection. (A) Representative sections are given for glomeruli and tubulo-interstitium at 6 hours after LPS injection. (Reproduction of this figure in color was made possible by a grant from Aventis Pharma, Bad Soden, Germany.) (B) Quantification of MCA519-positive cells per glomerular cross sectional and interstitial areas in time intervals after LPS-injection. Symbols are: (▪) ICAM-1 wild-type mice; (□) ICAM-1 knockout mice; *P < 0.05 when wild-type animals were compared with ICAM-1 knockout mice. Kidney International 2002 62, 1264-1276DOI: (10.1111/j.1523-1755.2002.kid572.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 7 Renal RANTES/CCL5 mRNA expression in ICAM-1 knockout and wild-type mice. RNA was extracted from renal tissue of mice (N = 3) at 12 and 24 hours after LPS was injected intraperitoneally. This figure is representative of three independent complete sets of experiments. Significance values are: *P at least <0.05 when compared with controls; #P < 0.05 when compared with wild-type animals after LPS-injection. Kidney International 2002 62, 1264-1276DOI: (10.1111/j.1523-1755.2002.kid572.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 8 RANTES/CCL5 mRNA expression in renal parenchymal cells after in vitro LPS-stimulation. Renal parenchymal single cell suspensions were prepared from ICAM-1 knockout and wild-type mice and stimulated in vitro for 24 hours with LPS or a combination of LPS and IFN-γ. When compared with controls (lane 1) there was a significant increase (P < 0.01) in RANTES/CCL5 mRNA expression after stimulation with high doses of LPS or the combination of LPS and IFN-γ (lanes 3 and 4). The increase in RANTES/CCL5 expression at a low LPS concentration in wild-type animals (lane 2) was not consistently reproduced and might be due to some contamination during the single cell preparation procedure. The figure is representative of two independent complete sets of experiments. Kidney International 2002 62, 1264-1276DOI: (10.1111/j.1523-1755.2002.kid572.x) Copyright © 2002 International Society of Nephrology Terms and Conditions